Results 81 to 90 of about 463,148 (204)

Association between diabetic nephropathy and other diabetic microvascular and macrovascular complications

open access: yesSaudi Journal of Kidney Diseases and Transplantation, 2008
Diabetic nephropathy is found to be significantly associated with diabetic retino-pathy and coronary artery disease. Few studies have also shown an association between diabetic nephropathy and neuropathy, and peripheral vascular disease.
Chandy Anila   +3 more
doaj  

The association between testosterone levels and diabetic nephropathy in Egyptian men with type 1 Diabetes Mellitus

open access: yesEndocrine and Metabolic Science
Background: Type 1 diabetes mellitus is a chronic illness characterized by the body's inability to produce insulin due to the autoimmune destruction of beta cells in the pancreas. It can develop in adults and is often onset in childhood.
Mina Michael Nesim   +4 more
doaj   +1 more source

DIABETIC NEPHROPATHY [PDF]

open access: yesThe Journal of Clinical Endocrinology & Metabolism, 1955
openaire   +2 more sources

The Therapeutic Effects of Sevelamer on Blood Sugar, HbA1c, Lipid Profile, and hs-CRP in Patients with Diabetic Nephropathy [PDF]

open access: yes
Background: Diabetic nephropathy (DN) is one of the major complications of diabetes. Hyperglycemia, inflammation and oxidative stress as well as advanced glycation end products (AGEs) are reported as the risk factors for DN. Sevelamer has shown promising
محمدی کبار, سوسن   +5 more
core  

Incidence and Predictors of Diabetic Nephropathy among Type 2 Diabetes Mellitus Patients, Southern Ethiopia

open access: yesJournal of Nutrition and Metabolism
Background. Diabetic nephropathy is the most common cause of end-stage renal disease, and it brings high morbidity and mortality. Globally, the predominant rise in type II diabetes prevalence significantly increases the incidence of diabetic nephropathy.
Fasika Merid   +3 more
doaj   +1 more source

Underuse of Ace Inhibitors and Angiotensin Ii Receptor Blockers among Patients with Diabetic Nephropathy in Taiwan

open access: yes, 2012
Objectives: National guidelines recommend angiotensin- converting enzyme inhibitors (ACE15) or angiotensin receptor blockers (ARBs) therapy for diabetic patients with hypertension and/or proteinuria to hinder renal disease progression. However, little is
YEH, HSENG-LONG;HUANG, LOREEN LI-YING;SU, SYI;YANG, MING-CHIN   +1 more
core   +1 more source

Tubulointerstitial disease in diabetic nephropathy

open access: yes, 2014
Giancarlo Tonolo, Sara Cherchi SC Diabetologia Aziendale ASL 2 Olbia, Hospital San Giovanni di Dio, Olbia, Italy Abstract: Diabetes mellitus is the major cause of end stage renal disease (ESRD). We cannot predict which patient will be affected.
Cherchi S, Tonolo G
core  

Non-Proteinuric Diabetic Nephropathy

open access: yes, 2015
Diabetic nephropathy patients traditionally show significant macroalbuminuria prior to the development of renal impairment. However, this clinical paradigm has recently been questioned.
Nicolas Robles   +2 more
core   +1 more source

C-Peptide : The missing link in diabetic nephropathy?

open access: yes, 2009
Proinsulin C-peptide has been found to exert beneficial effects in many tissues affected by diabetic microvascular complications, including the kidneys. Glomerular hyperfiltration and microalbuminuria are early markers of diabetic nephropathy.
Wahren, J,   +3 more
core   +1 more source

Circulating long non-coding RNAs MALAT1 and CASC2 as biomarkers for diabetic nephropathy in type 2 diabetic patients

open access: yesThe Egyptian Journal of Internal Medicine
Background Diabetic nephropathy (DN) exists as a serious renal condition brought on by destruction to the kidney’s glomerular blood capillaries. Glomerular and tubular damage biomarkers may predict early renal failure and structural abnormalities before ...
Hala A. Abdel-Azeez   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy